China Pharma Holdings, Inc. (CPHI): Price and Financial Metrics

China Pharma Holdings, Inc. (CPHI)

Today's Latest Price: $0.41 USD

0.01 (-2.33%)

Updated Apr 8 8:04pm

Add CPHI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 117 in China

See all "A" rated Strong Buy stocks

CPHI Stock Summary

  • With a year-over-year growth in debt of -39.09%, China Pharma Holdings Inc's debt growth rate surpasses merely 7.35% of about US stocks.
  • As for revenue growth, note that CPHI's revenue has grown -14.05% over the past 12 months; that beats the revenue growth of only 13.16% of US companies in our set.
  • The volatility of China Pharma Holdings Inc's share price is greater than that of 94.8% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to CPHI, based on their financial statements, market capitalization, and price volatility, are HEBT, GV, NX, LUB, and DMLP.
  • CPHI's SEC filings can be seen here. And to visit China Pharma Holdings Inc's official web site, go to
CPHI Daily Price Range
CPHI 52-Week Price Range

CPHI Stock Price Chart More Charts

CPHI Price/Volume Stats

Current price $0.41 52-week high $1.40
Prev. close $0.42 52-week low $0.21
Day low $0.39 Volume 1,119,000
Day high $0.45 Avg. volume 3,824,134
50-day MA $0.58 Dividend yield N/A
200-day MA $0.35 Market Cap 17.88M

CPHI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

We started the process of determining a valid price forecast for China Pharma Holdings Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that China Pharma Holdings Inc ranked in the 10th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for China Pharma Holdings Inc ended up being:

  • The company's debt burden, as measured by earnings divided by interest payments, is -63.35 -- which is good for besting merely 3.52% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • Its compound free cash flow growth rate, as measured over the past 4.89 years, is -0.07% -- higher than just 20.37% of stocks in our DCF forecasting set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CPHI, try CPIX, ENDP, CMD, OSMT, and RVP.

CPHI Latest News Stream

Event/TimeNews Detail
Loading, please wait...

CPHI Latest Social Stream

Loading social stream, please wait...

View Full CPHI Social Stream

CPHI Price Returns

1-mo -29.32%
3-mo 22.83%
6-mo 58.91%
1-year 0.29%
3-year 57.69%
5-year 32.26%
YTD 73.14%
2019 -7.86%
2018 42.78%
2017 -30.77%
2016 62.50%
2015 -46.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8228 seconds.